Edition:
United Kingdom

Cigna Corp (CI.N)

CI.N on New York Stock Exchange

198.66USD
17 Dec 2018
Change (% chg)

-- (--)
Prev Close
$198.66
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
518,170
52-wk High
$227.12
52-wk Low
$163.02

Chart for

About

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company's segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations... (more)

Overall

Beta: 0.47
Market Cap(Mil.): $48,077.03
Shares Outstanding(Mil.): 251.78
Dividend: 0.04
Yield (%): 0.02

Financials

  CI.N Industry Sector
P/E (TTM): 22.00 23.14 34.40
EPS (TTM): 8.68 -- --
ROI: -- -0.02 14.96
ROE: 16.12 16.79 16.53

Cigna boosts 2018 forecast after third quarter earnings beat

U.S. health insurer Cigna Corp , which is in the process of acquiring Express Scripts Holding Co , significantly bumped up its 2018 adjusted profit forecast, and its shares rose more than 3 percent on Thursday.

01 Nov 2018

UPDATE 3-Cigna boosts 2018 forecast after third quarter earnings beat

* Shares up 3.1 percent at $220.26 (Adds details from conference call, analyst quote, shares)

01 Nov 2018

Cigna's third-quarter profit rises driven by lower medical costs

Nov 1 Cigna Corp on Thursday reported a higher third quarter profit, helped by lower medical costs in its government healthcare plans.

01 Nov 2018

Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva

LOS ANGELES Express Scripts Holding Co , one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc , but exclude a rival medication from Teva Pharmaceutical Industries Ltd after price negotiations with all three manufacturers.

17 Oct 2018

Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva

LOS ANGELES Express Scripts Holding Co, one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc, but exclude a rival medication from Teva Pharmaceutical Industries Ltd after price negotiations with all three manufacturers.

17 Oct 2018

Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva

LOS ANGELES Express Scripts Holding Co, one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc, but exclude a rival medication from Teva Pharmaceutical Industries Ltd after price negotiations with all three manufacturers.

17 Oct 2018

UPDATE 1-Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva

LOS ANGELES Oct 17 Express Scripts Holding Co , one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc, but exclude a rival medication from Teva Pharmaceutical Industries Ltd after price negotiations with all three manufacturers.

17 Oct 2018

CVS, Aetna win U.S. approval for $69 billion deal

WASHINGTON/NEW YORK Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc , the Justice Department said on Wednesday, paving the way for a combination with potential to cut U.S. healthcare costs for consumers. | Video

10 Oct 2018

CVS, Aetna win U.S. approval for $69 billion deal

WASHINGTON/NEW YORK Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc , the Justice Department said on Wednesday, paving the way for a combination with potential to cut U.S. healthcare costs for consumers. | Video

10 Oct 2018

UPDATE 3-CVS, Aetna win U.S. approval for $69 bln deal

WASHINGTON/NEW YORK, Oct 10 Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc, the Justice Department said on Wednesday, paving the way for a combination with potential to cut U.S. healthcare costs for consumers.

10 Oct 2018

Earnings vs. Estimates